Z
Zhaoyun Liu
Researcher at Peking Union Medical College
Publications - 8
Citations - 180
Zhaoyun Liu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Breast cancer & Metastatic breast cancer. The author has an hindex of 3, co-authored 8 publications receiving 53 citations. Previous affiliations of Zhaoyun Liu include Shandong University.
Papers
More filters
Journal ArticleDOI
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib.
TL;DR: Li et al. as mentioned in this paper investigated GPX4-mediated ferroptosis in gefitinib sensitivity in triple negative breast cancer (TNBC) and found that inhibition of GPX 4 enhanced the anticancer effect of gefinib through promoting cell ferroidosis.
Journal ArticleDOI
Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
Chenxi Yuan,Chenxi Yuan,Zhaoyun Liu,Zhaoyun Liu,Qian Yu,Xinzhao Wang,Mengxue Bian,Mengxue Bian,Zhiyong Yu,Jinming Yu +9 more
TL;DR: It was observed that the presence of PD-1/PD-L1 positivity in metastatic lymph nodes was significantly associated with poor prognostic features, such as a high Ki-67 index, a high TNM stage, and a high histology grade.
Journal ArticleDOI
EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
TL;DR: The role of EGFR and STAT3 in breast cancer development and progression is investigated through bioinformatics analysis and QRT-PCR and Western blot analysis to find EGFR promotes breast cancer progression via STAT3 phosphorylation and JAK/STAT3 signaling.
Journal ArticleDOI
Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study.
Chao Li,Chao Li,Xiaoli Bian,Zhaoyun Liu,Xinzhao Wang,Xiang Song,Wei Zhao,Yansong Liu,Zhiyong Yu +8 more
TL;DR: In this article, the authors investigated the real-world data of pyrotinib in complex clinical practice and complement the findings of clinical trials, and the results showed that the toxicity of pyrinib was tolerable, with the most common grade 3/4 adverse event being diarrhea (19.8%).
Journal ArticleDOI
Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer
TL;DR: In this paper, the authors analyzed the relationship between Nox4 and lymphangiogenesis and found out whether the newborn lymphatic vessels lead to cancer metastasis, which is a potential target of antitumor metastasis.